STOP Nitazenes Act
- Sponsor
- Rep. Latta, Robert E. [R-OH-5]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jul 21, 2026
Bottom line
This bill permanently classifies nitazenes as Schedule I controlled substances, making their possession, manufacture, and distribution illegal under federal law.
What it actually does
This bill permanently schedules 2-benzylbenzimidazole opioids, commonly known as nitazenes, as Schedule I controlled substances under the Controlled Substances Act. It provides a detailed chemical definition for these substances and explicitly lists several common nitazenes, while also granting the Attorney General authority to publish additional substances that meet the definition. This action aims to combat the illicit trafficking and abuse of these potent synthetic opioids.
Proponents argue
Proponents argue that permanently scheduling nitazenes is a critical step to combat the opioid crisis, as these substances are extremely potent, dangerous, and often found in the illicit drug supply, contributing to overdose deaths. They contend that this measure provides law enforcement with necessary tools to prosecute traffickers and prevent the spread of these deadly drugs, closing potential loopholes that temporary scheduling might leave.
Opponents contend
Opponents, if any, might argue that broad scheduling measures could inadvertently criminalize research into these substances, which might have potential medical applications, or that it primarily addresses supply without tackling underlying demand issues. However, given the public health crisis associated with nitazenes, direct opposition to scheduling is uncommon.
The bill is short and its core purpose is clear, making it accessible for a quick but informed review.
Section 2(a)
Permanent Scheduling of Nitazenes
This provision amends the Controlled Substances Act to permanently classify all 2-benzylbenzimidazole opioids (nitazenes) as Schedule I controlled substances. This means that these drugs are deemed to have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision, making their manufacture, distribution, and possession illegal under federal law.
Supporters argue
Supporters argue that this permanent scheduling is crucial for public safety, as nitazenes are extremely potent and deadly synthetic opioids contributing significantly to the overdose crisis. They assert that permanent classification provides a stable legal framework for law enforcement to combat trafficking effectively.
Critics contend
No specific opposition is typically raised against the permanent scheduling of highly dangerous synthetic opioids with no recognized medical use, as it is widely seen as a necessary public health measure.
Tradeoffs
The primary tension involves balancing the need for swift action against dangerous drugs with the potential for over-criminalization, though in this case, the extreme danger of nitazenes generally outweighs such concerns for policymakers.
Section 2(a), new subsection (f)(2)
Comprehensive Definition of Nitazenes
This provision provides a detailed chemical definition for "2-benzylbenzimidazole opioid," outlining specific structural modifications that characterize these substances. It also includes a functional definition (substances exhibiting agonist activity at the mu-opioid receptor) and explicitly lists several known nitazene compounds. This comprehensive definition aims to prevent illicit manufacturers from making minor chemical alterations to evade scheduling.
Section 2(b)
Permanent Status for Previously Temporarily Scheduled Nitazenes
This subsection ensures that any nitazene substances that were previously temporarily scheduled by the Attorney General under emergency powers will automatically become permanently scheduled as Schedule I controlled substances upon the enactment of this Act. This streamlines the process and avoids any lapse in legal control over these dangerous drugs.
Section 3
Implementation Rulemaking Authority
This section directs the Attorney General to issue rules to implement the Act within one year of enactment, allowing for the use of an interim final rule. An interim final rule can take effect immediately without a prior notice-and-comment period, but the Attorney General must still provide an opportunity for public comment and a hearing before issuing a final rule. This ensures rapid implementation while preserving public input.
This subsection provides a highly technical, class-based chemical definition for 2-benzylbenzimidazole opioids, outlining specific structural modifications at various positions (1-position, 2-position, phenyl portion of benzimidazole ring, and 6-position).
Section 2(a), new subsection (f)(2)(A)
Why it matters:This is standard legislative practice for defining controlled substances, as precise chemical definitions are necessary for legal enforceability and to prevent evasion by minor structural changes. It is not intended to be evasive but is inherently complex.
Case for: Proponents argue that this detailed, class-based definition is crucial for preventing illicit manufacturers from creating 'designer drugs' that are chemically similar but technically unscheduled, thereby closing a significant loophole in drug control efforts.
Case against: Some critics of broad chemical definitions, in general, express concern that they could inadvertently capture substances with legitimate uses or that are not psychoactive, though this is less likely with a specific and dangerous class like nitazenes.
Estimated impact: Significantly broadens the scope of substances covered under Schedule I, impacting the entire illicit market for synthetic opioids.
This subsection authorizes the Attorney General to publish a list of substances in the Federal Register that satisfy the definition of a '2-benzylbenzimidazole opioid' in paragraph (2).
Section 2(a), new subsection (f)(3)
Why it matters:This is a standard administrative clarification mechanism. It's not intended to be evasive but rather to provide practical guidance to the public and law enforcement on which specific compounds fall under the broad class definition without requiring new legislative action for each one.
Case for: Proponents argue that this authority allows the Attorney General to provide clarity and public notice regarding specific nitazene compounds that are covered by the class definition, aiding law enforcement and public understanding without the need for further rulemaking or legislation.
Case against: No specific opposition is typically raised against this type of administrative clarification, as it does not create new law but rather interprets existing law.
Estimated impact: Enhances the practical enforceability and clarity of the class scheduling by providing an official, publicly accessible list of covered substances.